ISRCTN62596811Active, not recruiting未知
Effects on cervical high-risk human papillomavirus clearance in patients undergoing treatment with vaginal gel based on carboxy-methyl-beta-glucan in polycarbophil plus an oral probiotic containing L. rhamnosus TOM 22.8 strain: a randomized controlled trial
Ospedale dei Bambini Vittore Buzzi0 sites80 target enrollmentStarted: September 11, 2022Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •1. Women aged 30-45 years
- •2. Persistent positive cytological LSIL and/or histological CIN 1 and/or HPV HR test for at least 12 months
- •3. Absence of contraindications to the proposed therapies
- •4. Read and signed informed consent
Exclusion Criteria
- •1. Active vulvovaginal infections at the time of their gynaecological examination
- •2. Genital bleeding of unknown origin
- •3. Pregnancy
- •4. Menopause (absence of menstruation for 12 months)
- •5. Diagnosis of or under therapy for previous CIN2+ lesions
- •6. Immune-depressed, or with infections caused by human immunodeficiency virus (HIV-positive)
- •7. Patients concomitantly included in different interventional clinical trials
- •8. Unwillingness to provide informed consent to the trial
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Correlation of high risk Human Papilloma Virus and Chlamydia Trachomatis infection with cervical cancer and precancerous conditions.CTRI/2020/06/025610All India Institute of Medical Sciences Rishikesh
Active, not recruiting
Not Applicable
Participation of the HPV virus in the appearance of laryngeal papillomas in patients from São Luís, MaranhãopapillomaRBR-788y7cIVERSIDADE FEDERAL DO MARANHÃO
Completed
Not Applicable
Efficacy of addition of high-risk human papillomavirus (hrHPV) testing by Hybrid Capture II to conventional cytological screening for cervical cancerCervical intraepithelial neoplasiaCarcinoma in situ of cervix uteriCancerISRCTN64621295SALTRO - Doctor Laboratory & Thrombosis Service (The Netherlands)25,000
Recruiting
Not Applicable
Evaluation of the effect of education in the prevention and treatment of human papillomavirusIcd_10.IRCT20220131053891N1Shiraz University of Medical Sciences90
Completed
Not Applicable
Infection of human papillomavirus and overexpression of P16 in cervical neoplasiaJPRN-UMIN000000585Keio University, School of Medicine300